Columbia Laboratories to Discuss Third Quarter 2006 Financial Results on
November 9, 2006 Conference Call
LIVINGSTON, NJ – October 23, 2006 - Columbia Laboratories, Inc. (NASDAQ: CBRX) will hold a conference call on November 9, 2006, to review and discuss financial results of the third quarter and nine months ended September 30, 2006. Robert Mills, Columbia’s president and chief executive officer, and David Weinberg, chief financial officer, will host the call.
Access information
| Date: | Thursday, November 9, 2006 |
| Time: | 11:00 AM ET |
| U.S./Canada dial-in number: | (800) 753-0420 |
| International dial-in number: | (913) 981-5554 |
| Participant passcode: | 8564426 |
| Live webcast: | www.columbialabs.com under "Events" in the Investor section |
The replay passcode is 8564426. The webcast will be archived for on-demand listening for one year on Columbia Laboratories’ website, www.columbialabs.com, under "Events" in the Investor section.
About Columbia Laboratories, Inc.
Columbia Laboratories, Inc. is a U.S.-based international pharmaceutical company dedicated to the development and commercialization of reproductive healthcare and endocrinology products that use its novel bioadhesive drug delivery technology. Columbia markets PROCHIEVE® 8% (progesterone gel) for progesterone supplementation as part of an Assisted Reproductive Technology treatment for infertile women with progesterone deficiency and PROCHIEVE® 4% (progesterone gel) for the treatment of secondary amenorrhea. The Company also markets STRIANT® (testosterone buccal system) for the treatment of hypogonadism in men. The Company recently completed enrollment in a large-scale pivotal Phase III study to evaluate the possible utility of PROCHIEVE® 8% (progesterone gel) in the prevention of recurrent preterm birth. This randomized, double-blind, placebo-controlled trial involves 669 patients at more than 60 centers globally. The Company’s additional research and development programs include a vaginally-administered lidocaine product to treat dysmenorrhea. For more information, please visit www.columbialabs.com.
PROCHIEVE® and STRIANT® are registered trademarks of Columbia Laboratories, Inc.
###